-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Meridian Bioscience Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
- Meridian Bioscience Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2022 was -$2.52M, a 77.2% increase year-over-year.
- Meridian Bioscience Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$34.3M, a 10.4% decline from 2021.
- Meridian Bioscience Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$31.1M, a 773% decline from 2020.
- Meridian Bioscience Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$3.56M, a 124% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)